Who is sponsoring NCT06157632?

NCT06157632 is sponsored by Assiut University.

What drugs are being tested in NCT06157632?

Interventions in NCT06157632: Thyriodectomy.

What condition does NCT06157632 study?

NCT06157632 studies Level of Thyrogobulin in Different Thyroid Nodules.

Is NCT06157632 still recruiting?

NCT06157632 is currently status unknown. Last updated 6 December 2023.

Last reviewed 2023-12-06 · How we verify

NCT06157632

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Preoperative Serum Thyroglobulin Level to Differentiate Between Different Thyroid Nodules

Status unknown NA Last updated 6 December 2023

What this trial tests

NA trial testing Thyriodectomy in Level of Thyrogobulin in Different Thyroid Nodules in 30 participants. Status unknown.

Timeline

20 December 2023

Primary endpoint
18 November 2024

25 November 2024

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	30
Start date	20 December 2023
Primary completion	18 November 2024
Estimated completion	25 November 2024

Drugs / interventions tested

Thyriodectomy

Conditions studied

Level of Thyrogobulin in Different Thyroid Nodules — all drugs for Level of Thyrogobulin in Different Thyroid Nodules →

Sponsor

Assiut University

Who can join

Adults 15 to 70, any sex, with Level of Thyrogobulin in Different Thyroid Nodules. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Role of preoperative serum thyroglobulin level to differentiate between different thyroid nodules

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06157632 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 6 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06157632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing